PMID: 9194169Apr 1, 1997Paper

Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment

Protein Engineering
L NiebaA Plückthun

Abstract

By constructing Fv and single-chain Fv (scFv) fragments of antibodies, the variable domains are taken out of their natural context in the Fab fragment, where they are associated with the constant domains of the light (CL) and heavy chain (CH1). As a consequence, all residues of the former variable/constant domain interface become solvent exposed. In an analysis of 30 non-redundant Fab structures it was found that at the former variable/constant domain interface of the Fv fragment the frequency of exposed hydrophobic residues is much higher than in the rest of the Fv fragment surface. We investigated the importance of these residues for different properties such as folding in vivo and in vitro, thermodynamic stability, solubility of the native protein and antigen affinity. The experimental model system was the scFv fragment of the anti-fluorescein antibody 4-4-20, of which only 2% is native when expressed in the periplasm of Escherichia coli. To improve its in vivo folding, a mutagenesis study of three newly exposed interfacial residues in various combinations was carried out. The replacement of one of the residues (V84D in VH) led to a 25-fold increase of the functional periplasmic expression yield of the scFv fragment of the a...Continue Reading

Citations

Jul 9, 1999·Journal of Molecular Recognition : JMR·S Muyldermans, M Lauwereys
Oct 20, 2006·Applied Microbiology and Biotechnology·Leonardo M DamascenoCarl A Batt
Jan 13, 2006·Cancer Metastasis Reviews·Mehdi Arbabi-GhahroudiRoger MacKenzie
Jul 31, 2013·The Protein Journal·Gopal Jee Gopal, Awanish Kumar
Sep 15, 2000·Journal of Immunological Methods·B E Power, P J Hudson
May 16, 2002·Journal of Immunological Methods·Jamshid TanhaC Roger MacKenzie
Mar 4, 2000·Journal of Immunological Methods·Y LiG C Whitelam
Jun 11, 2002·Journal of Molecular Biology·Markus KaufmannMarkus G Grütter
Dec 25, 2002·Journal of Molecular Biology·Stefan EwertAndreas Plückthun
Jun 26, 2003·Journal of Molecular Biology·Marcello DoniniEugenio Benvenuto
Apr 6, 1999·Trends in Biotechnology·A Cattaneo, S Biocca
Aug 28, 1998·Current Opinion in Biotechnology·P J Hudson
Jul 17, 1998·Current Opinion in Biotechnology·E D B Clark
Sep 8, 1998·Current Opinion in Structural Biology·W Dall'Acqua, P Carter
Oct 31, 2002·Protein Expression and Purification·Jessica R Sinacola, Anne S Robinson
Jun 1, 1997·Immunotechnology : an International Journal of Immunological Engineering·A Plückthun, P Pack
Aug 31, 2001·Journal of Biotechnology·S Muyldermans
Jun 2, 2012·Biochemistry·Kevin C EntzmingerJennifer A Maynard
Dec 22, 1999·British Journal of Haematology·A RostagnoJ Ghiso
Feb 9, 2000·Letters in Applied Microbiology·P M CupitC Cunningham
Dec 20, 2003·Hybridoma and Hybridomics·Stephen HamiltonJörg-M Kupsch
Oct 28, 2009·Hybridoma·Pooja GoswamiSubrata Sinha
Apr 10, 2010·Protein Engineering, Design & Selection : PEDS·Erik KvamAnne Messer
Jul 6, 2012·Protein Engineering, Design & Selection : PEDS·Jonas V Schaefer, Andreas Plückthun
Jul 31, 2012·Protein Engineering, Design & Selection : PEDS·Joseph M PerchiaccaPeter M Tessier
Sep 24, 1999·Protein Science : a Publication of the Protein Society·K L MaxwellA R Davidson
Mar 23, 2011·Biochemistry. Biokhimii︠a︡·E P AltshulerA G Katrukha
Nov 10, 2001·Annual Review of Biomedical Engineering·J Maynard, G Georgiou
Apr 26, 2005·Microbial Cell Factories·Salvador Ventura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.